The role of central cholinergic blockage in spatial learning was examined by testing atropine' sulfate-treated (50 mg/kg) rats and saline-injected controls in the Morris water task using training procedures designed to promote the use of a spatial search strategy. First, constraints used in early trials deterred thigmotaxis. Second, an originally oversized hidden platform that nearly occupied the entire pool was effectively "shrunk" into the southwest quadrant of the pool by substituting smaller platforms over trials, a procedure intended to focus attention on the hidden platform in relation to extramaze cues. Task acquisition did not differ between groups, and on the probe trial both groups increased distance and latency and swam preferentially in the previously correct quadrant. Impairments caused by atropine sulfate may be the result of deficits in ability to inhibit nonefficient escape strategies.
The Morris water task (MWT; Morris, 1981) has been used widely to assess drug-, aging-, or brain injury-induced spatial navigation function in rats. Damage to subregions of the neocortex (Kolb, Sutherland, & Whishaw, 1983) , the hippocampus (Morris, Garrud, Rawlins, & O'Keefe, 1982; Sutherland, Whishaw, & Kolb, 1982) , or its connections (e.g., the fimbriafornix pathways; Whishaw, 1995) and the administration of centrally acting anticholinergic drugs (e.g., Lindner & Schallert, 1988; Sutherland, Whishaw, & Regehr, 1982; Whishaw, 1985) or neurotoxins (Nilsson, Hillered, Ponten, & Ungerstedt, i990 ) disrupt the ability to use distal cues to locate the hidden platform in the MWT. In addition, traumatic brain injury (Bramlett et al., 1995; Hamm, Lyeth, Jenkins, O'Dell, & Pike, 1993) , stroke (Green et al., 1992) , and normal aging (Gage, Dunnett, & Bjorklund, 1984; Gallagher, Burwell, & Burchinal, 1993; Rapp, Rosenberg, & Gallagher, 1987 ; but see Lindner & Schallert, 1988) cause learning deficits in the MWT similar to deficits caused by anticholinergic drugs or by specific damage to the hippocampus or neocortex.
The nature of the learning deficit in the MWT is not obvious when evaluating simple acquisition. A number of tactics can be used by the animal to navigate to the hidden platform with increasing accuracy over trials. A place-learning strategy, the Lainy Baird Day and Timothy Schallert, Department of Psychology and Institute for Neuroscience, University of Texas at Austin.
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Correspondence concerning this article should be addressed to Timothy Schallert, Department of Psychology, University of Texas, Austin, Texas 78712. Electronic mail may be sent via Internet to TSchallert@mail.utexas.edu. most efficient strategy, in the MWT is characterized by flexible swim paths and is believed to require relational associations between distal cues and the platform location. Taxis strategies involve approach .toward or avoidance of a specific environmental cue that signals the platform location. Praxis strategies are specific sets of repetitive motor responses that lead to contact with the goal object (Whishaw, 1985) . Although rats treated with anticholinergic drugs and rats for which the platform has been moved randomly learn how to locate a hidden platform and become more efficient at escape across trials (Sutherland, Whishaw, & Regehr, 1982) , they appear to use praxis or taxis strategies rather than a place strategy (Whishaw, 1985) .
To determine whether a place strategy is used by the animal, researchers have traditionally conducted probe tests that involve moving the platform to a new area of the pool (Lindner & Schallert, 1988; Morris, 1981; Whishaw, 1995) . If an animal is using a place strategy, it continues to search for the platform in the original location, which results in higher latencies and longer swim paths on a probe trial. Unless given extensive training (Whishaw, 1985) , atropine sulfate-treated rats will often rely on a praxis strategy that involves, for example, swimming in concentric circles of decreasing diameter until the platform is encountered (Lindner & Schallert, 1988; Sutherland, Whishaw, & Regehr, 1982; Whishaw, 1985) . When the platform is moved to a novel location during probe trials, these animals do not swim preferentially in the old platform location, and performance on the probe trials is not characterized by an increase in latency and distance to find the platform in a new position. Thus, acquisition alone does not assess the strategy used to locate the platform; however, performance on probe trials can roughly distinguish a place strategy from other strategies used to find the hidden platform. If training is extensive, atropine sulfate-treated animals can eventually switch from praxis to place strategies as demonstrated by increased latency on probe trials. However, scores are not comparable with those of controls, suggesting that slow acquisition is due to impairments in formation of a spatial map.
Given that rats treated with anticholinergic drugs tend to rely, at least initially, on nonplace strategies to acquire the MWT (Sutherland, Whishaw, & Regehr, 1982; Whishaw, 1985 Whishaw, , 1995 but may eventually demonstrate place learning, we suggest, as others have (Lindner & Schallert, 1988; Whishaw, 1995) , the possibility that disruption of function through administration of a cholinergic antagonist is mediated at least in part by entrapment in inefficient strategies rather than by impairment in the formation of a cognitive map (see O'Keefe & Nadel, 1978) . Consistent with this view, Whishaw (1995) recently showed that by adding a few special training techniques rats with fimbria-fornix lesions can form a place response, albeit imprecise, in fewer trials than has been necessary in the past. Before running traditional hidden platform trials, he habituated the animals to the testing environment, gave extensive training with a visually cued platform, and then, during initial hidden platform trials, once an animal had entered the quadrant containing the platform, removed them from the pool before they could exit that quadrant. Although the latencies to reach the platform were still longer than that of control animals, detailed kinematic analysis showed that, like controls, the fimbria-fornix lesioned rats demonstrated apparent place learning by slowing down when they swam close to the platform. This suggests that the deficit was primarily one of accuracy rather than spatial mapping.
Under more traditional testing, animals are allowed to continue swimming after missing the platform. It may be that missing the goal repeatedly causes animals to rely on less efficient nonplace strategies. We hypothesized that special training procedures might discourage formation of inefficient strategies such that atropine-treated animals could form an accurate spatial map with a minimal number of trials.
Our first experiment was conducted to confirm results of previous studies (e.g., Lindner & Schallert, 1988; Sutherland, Whishaw, & Regehr, 1982) showing that, in a standard MWT procedure, atropine sulfate-treated rats given a limited number of training trials do not demonstrate a convincing place response during acquisition or probe trials. In the second experiment, we used simple procedures to discourage praxis and taxis strategies. During initial trials, a Plexiglas tunnel prevented the animals from swimming in circles along the perimeter of the pool (i.e., thigmotaxis; Lindner & Schallert, 1988) , a behavior that control rats often demonstrate in initial trials but quickly abandon. In addition, we began the second experiment using an extremely large platform that occupied most of the pool and replaced it with increasingly smaller platforms every three blocks (blocks consist of four trials).
sulfate-treated group, and 6 rats were assigned to a saline-treated control group.
Apparatus. We used a large, circular pool 1.83 m in diameter and 0.61 m high. The pool was painted white to eliminate intramaze cues and was filled with water to a depth of 25.6 cm. A white rectangular platform (19 x 22 cm) was submerged 2.5 cm below the surface of the water and was placed in the center of one quadrant of the pool arbitrarily labeled the southwest (SW) quadrant. In like fashion, the other three quadrants were designated southeast (SE), northeast (NE), and northwest (NW). We used four release sites along the edge of the wall at the SE, SW, NE, and NW. Placements of the platform within the pool and the pool within the room were marked and checked for alignment before testing sessions. White Styrofoam beads (0.5-1.5 mm diameter) covered the surface of the pool and blocked any view of the platform (Lindner & Schallert, 1988) . The room had several prominent cues located about 62 cm above and 62 cm away from the edge of the pool.
Drug administration. Twenty minutes before testing each day, atropine sulfate-treated rats were weighed and injected intraperitoneally with 50 mg/kg atropine sulfate (Lindner & Schallert, 1988; Sutherland, Whishaw, & Regehr, 1982; Whishaw, 1985) . This dose is sufficient to block spatial ability (Lindner & Schallert, 1988; Sutherland, Whishaw, & Regehr, 1982) and produces impairments equivalent to those seen in animals given 100 mg/kg atropine sulfate (Whishaw, 1985) . In addition, this dose saturates muscarinic ACh receptors in rat brain as indicated by (3H)-QNB binding studies (Yamamura, Kuhar, & Snyder, 1974) . Control rats were injected with an equal volume of saline. The rats were carried in travel cages 2 to a cage into the experimental room, where they remained for at least 15 min before testing.
Procedure. Animals completed two blocks of four trials each day for 6 days. On the first trial of Day 1 only, rats were placed on the platform for 60 s. Only the next three trials of this first block were included in the analysis. Between trials, rats were held in an opaque box that had a White noise generator attached to it to minimize sound cues. Rats were held by the torso and placed in the pool gently so that their heads did not go below the surface of the water. Within each four-trial block, rats were released randomly at the outer wall in one of the four quadrants at points designated NW, SW, SE, and NE. For half of the trials (randomly distributed), rats faced the center of the pool when released, and for the other half of the trials, rats faced the wall of the pool when released. Swim latencies and swim paths were recorded as in Lindner and Schallert (1988) . If the rat found the platform within 120 s, it was allowed to rest on the platform for 10 s. If the animal had not found the platform within this time, it was placed on the platform for 10 s. The rat was put back into the opaque box for 30 s while the pool was stirred to remove possible olfactory cues. The time between the two blocks of daily trials was approximately 10 min. On Day 7 (Block 13), a probe trial was conducted. The platform was placed in the center of the quadrant diagonally opposite the training quadrant for one block of four trials. After each block, rats were thoroughly dried. When testing was completed they were carried back to their home cages.
Experiment 1

Method
Animals. Twelve male, hooded Long-Evans rats, aged 2.5-3 months at the beginning of the experiment and weighing between 350 g and 550 g across the testing period, were obtained from the breeding colony at the Animal Resource Center at the University of Texas. Animals were housed with litter mates, 3 to a cage (41 × 22 cm) in a room maintained on a 12:12-hr light-dark cycle, and had free access to food and water. Six rats were randomly assigned to the atropine
Results and Discussion
As expected (see Figure 1) , atropine sulfate-treated rats (mean -SE = 21.54 ---2.21) were not able to locate the platform as quickly as were control rats (11.65 -+ 1.18), and this difference in overall latency was significant, F(1, 10) = 16.17, p = .002. However, both groups showed a decline in latencies across blocks, F(ll, 110) = 8.75,p = .0001. That both groups improved performance is shown by a significant post hoc linear contrast for the atropine sulfate-treated group and for the controls.
Although the atropine-treated rats improved across trials, it is likely that these rats were not using a place strategy because swim time did not increase when the platform was relocated to the diagonally opposite quadrant. There was no significant difference between performance of atropine sulfate-treated rats on the last trial of training (10.92 _ 3.76) and the first probe trial (7.14 ---1.03), and the means are in the opposite direction one would predict if the rats knew the location of the platform. The decrease in latency across these trials suggests that the strategy that the atropine sulfate-treated rats used to locate the platform was as effective for reaching a random platform location as it was for reaching a trained location. Control rats took longer to find the platform on the first probe trial (14.28 ---2.89) than on the last training trial (6.31 ---1.73), t(5) = 3.71, p = .007. In addition, performance of the two groups on the probe trial was significantly different, t(10) = 2.33,p = .02.
The atropine sulfate-treated rats appear to have used a strategy that allowed improved performance over trials, but as suggested by a significant difference in escape latencies between groups, they never matched the efficiency and accuracy of the control rats. Similar significant differences between treatment groups have been reported with the use of cholinergic antagonists (Lindner & Schallert, 1988; Sutherland, Whishaw, & Regehr, 1982) , hippocampal lesions (e.g., DiMattia & Kesner, 1988; Morris et al., 1982; Sutherland, Whishaw, & Kolb, 1982) , or intracerebral infusion of the cholinergic immunotoxin, 192 IgGsaporin (Berger-Sweeney et al., 1994; Nilsson et al., 1992 ). An exception to this trend is noted in a recent report by Baxter, Bucci, Gorman, Wiley, and Gallagher (1995) that raises the possibility that the effects of systemic administration of anticholinergic agents may be more disruptive to spatial learning than anatomically selective interference of cholinergic function.
Improved performance, however, does not necessarily mean that animals mapped the spatial arrangement of extramaze cues. As Whishaw (1985) pointed out, rats can improve MWT performance using praxis or taxis navigation as well as spatial mapping. Thus, a crucial test for spatial mapping is not improved escape latency across trials but a probe test designed to demonstrate preference for the location of the platform during training after it has been moved or removed.
Because the control rats showed a significant increase in escape latency between the last trial of training and the first trial of the probe, whereas the atropine sulfate-treated rats showed a nonsignificant decline in latencies, we can infer that the control rats spent more time searching in the previously correct quadrant than did the atropine sulfate-treated rats. These data suggest that the control rats learned the place of the platform in relation to distal cues, whereas the atropine sulfate-treated rats leamed only how to locate the platform using a nonplace strategy.
Experiment 2
Atropine sulfate-treated rats may be capable of forming a spatial map, but they appear to be impaired in its use because of difficulties in overcoming thigmotaxis (Lindner & Schallert, 1988; Schallert, De Ryck, & Teitelbaum, 1980) and problems switching from an initial nonplace strategy to a place strategy. Therefore, it was our aim, in Experiment 2, to use special training procedures that discouraged thigrnotaxis or use of nonplace strategies.
Method
Animals. We used 12 naive male, hooded Long-Evans rats, age 2.5-3 months at the beginning of testing and weighing 310-490 g across testing. All animal care and housing procedures were the same as for Experiment 1.
Apparatus. The pool was the same as that used in Experiment 1.
The testing room had several prominent cues, such as shelves, silver shelving brackets, and paintings. The water level was again kept to 2.5 cm above the platform. For this experiment, seven different platform sizes were used in descending order. All platforms were made out of waterproof wall paneling 0.64 cm in thickness, painted white, and covered by wire mesh to improve footing for rats climbing onto the platform. The largest platform was 123.1 cm in diameter, and the smallest one was 30.78 cm in diameter. Platforms were anchored to concrete blocks by wing nuts to keep them submerged. Because the platforms decreased in size for every three trial blocks, they effectively "shrank" gradually (by 15.38 cm diameter increments) into the center of the southwest quadrant. A Plexiglas tunnel (30.78 x 30.78 x 30.78 cm) was placed between the wall and the platform during early training to prevent thigmotaxis and circling against the pool wall. Each rat was placed in the tunnel and had only a square foot of water surface to swim to the 123.1-cm diameter platform, thus preventing circling behavior from becoming reinforced. The animals would have had to swim beneath the surface of the water to escape the constraint area.
Procedure. Drug and basic testing procedures were the same as for Experiment 1. The same four points were again used as release sites, and rats were placed in the pool randomly facing toward or away from the wall. Latency and swim paths were recorded as in Lindner and Schallert (1988) . There were two blocks of trials per day. Olfactory and sound cues were controlled, and animals were carried to and from the home room in opaque cages, as in Experiment 1. Rats were allowed 60 s to find the platform and 20 s to rest on the platform after each trial. On Day 1, two blocks of four trials were conducted. The animals were placed on the largest platform nearest each of the four release sites for 60 s to help them become accustomed to its surroundings and to allow them to observe the room from many different vantage points. During this time, the animals were free to walk across the platform in order that they might find its edges and to spend time rearing (Sutherland, Whishaw, & Regehr, 1982) . On the first few trials of those blocks when the Plexiglas constraint was in position, rats would spend a few seconds attempting to climb on the walls of the pool and the constraint, but they quickly learned to head straight for the platform edge. For one block of trials, rats were released without the Plexiglas constraint, but if the rat swam out of the release quadrant, it was gently turned back to the center of the quadrant. Two more blocks were conducted using the largest platform without any constraints or interference by the experimenters. The first platform reduction consisted of one block of trials with the 107.7-cm platform. This was the first block used in the analysig. Thereafter, the platform was replaced every three blocks with a smaller platform anchored in the southwest quadrant. We added a fourth block to the last increment, when the smallest platform was being used. In the probe trials, the smallest platform was moved to the diagonally opposite quadrant.
Results and Discussion
Latency. Unlike past research (Lindner & Schallert, 1988; Sutherland, Whishaw, & Regehr, 1982; Whishaw, 1985 Whishaw, , 1995 , we found no significant difference between the performance of the atropine-treated animals (mean ___ SE = 4.24 _ 0.32) and the control animals (3.68---0.21) on latency to reach the hidden platform across blocks (see Figure 2) . A repeated measures analysis of variance (ANOVA), with treatment group and blocks as variables, indicated that there was a slight, but significant, increase in latency across trials due to the decreasing size of the platform, F(16, 160) = 7.97, p = .001 (see Figure 2) . However, there was no significant interaction.
Because the large size of the platform did not allow for large variation in performance in early blocks and because the primary focus of the study was on the performance of the animals when we used the smallest platform size and on the probe trial, we also performed an ANOVA over the four smallest platform blocks alone. There was no significant difference between treatment groups (atropine sulfate-treated rats ----6.94 __-0.73; controls = 5.94 ___ 0.50) across the four smallest platform blocks and no interaction. There was also no significant effect for latency across these four blocks.
The improved performance of both groups can be attributed to successful place responses. Performance on the first trial of platform relocation (probe trial) compared with the previous training trial indicated that both groups spent significantly more time searching for the platform during the probe trial than on the last trial of training: atropine sulfate-treated rats = 5.12 ± 1.10 on the last training trial versus 20.75 ± 4.40 on the probe trial, t(5) = 3.82,p = .006; control rats = 3.74 -1.16 on the last training trial versus 38.19 ± 7.27 on probe trial, t(5) = 4.52,p = .003.
Distance. Because improvement in latency does not always correspond to learning improvements, we also analyzed distance traveled to reach the platform. We used a cartographer's tool to measure the length of the swim paths that were drawn on a scaled map of the pool while animals were swimming. All distance measurements were transformed into meter equivalents. All effects for distance were similar to those of latency (see Figure 3) .
On the probe trial, when the platform was relocated, both groups greatly increased the distance traveled to reach the hidden platform: atropine sulfate-treated rats on last training trial = 1.69 ---0.37versus 8.95 ± 1.85 on the probe trial, t(5) = 4.2, p = .004; control rats = 1.18 ± 0.43 on last training trial versus 11.19 ± 1.92 on the probe trial, t(5) = 4.2,p = .002. We also noticed that atropine-treated rats swam faster than saline controls on the probe trial (0.36 ± 0.02 m/s vs. 0.28 ± 0.03 m/s). Apparently, atropine-treated rats swam faster instead of slowing down slightly after they encountered the original location of the platform and while they were swimming within the previously correct quadrant. We are currently planning to examine systematically this motor response to expectancy violation. This reaction might handicap atropine sulfatetreated animals, after a place-learning strategy is adopted, if task requirements are altered such that a nonplace strategy becomes optimal.
Percentage distance in the training platform quadrant. An analysis of the percentage of distance swum during the probe trial in the quadrant in which the platform had been during training is consistent with the interpretation that both groups were using place-learning strategies. There was no significant difference between atropine sulfate-treated rats (37---3.2) and controls (43 ± 3.6) in the percentage of the total length of the swim path that was swum in the quadrant that had contained the platform before relocation, t(10) = 1.26,p = .12.
A chi-square analysis shows that performance of both atropine sulfate-treated, ×2(1, N = 6) = 7.68, p = .006, and control, ×2(1, N --6) = 17.28, p < .00001, groups were significantly different from chance performance of 25% of total distance swum in each quadrant (see Figure 4) .
The evidence suggests that use of a constraining tunnel during initial training trials and platform reduction allowed animals treated with atropine sulfate to form a place response that was comparable with that of control animals. There were no significant differences between treatment groups on latency, distance, or percentage of distance swum in the original platform quadrant. In addition, both groups demonstrated place learning on the probe trials. Both groups significantly increased latency and distance between the last training trial and the probe trial. The groups did not differ on the percentage of distance swum in the old platform quadrant, and the percentage swum in the old platform was significantly different from chance for both groups. Moreover, both the atropine sulfate-treated rats and the control rats learned the new platform location rapidly even though on the probe trial they initially searched for the platform in its old location (see Figure 5 ). We have since replicated this second experiment using different rats.
We believe that this evidence offers a serious challenge to the view that intact brain cholinergic systems are necessary for the formation of a spatial map. Yet, we cannot generalize from our results with atropine sulfate-treated animals to aged animals or animals with hippocampal or other brain injury. Although Whishaw (1995) has been able to demonstrate the relation between place-learning strategy and the slowing of swim speed near the platform in rats after fimbria-fornix lesions, his animals were not able to locate the platform as fast as controls, whereas, in the present experiment, strategy selection-trained animals did not differ from controls. The present data are consistent with the view that the integrity of cholinergic synaptic function is not required for rapid acquisition of the MWT using a place-learning strategy. Instead, perhaps intact cholinergic function is necessary to overcome nonplace strategies and thereby permit a place-learning strategy. It remains possible that atropine sulfate-treated animals would not perform as well in a spatial task that challenges memory or attention more seriously (Baxter et al., 1995) because of an inability to develop inhibition of nonplace strategies in a quickly changing environment.
General Discussion
In Experiment 1 we demonstrated that rats treated with atropine sulfate used primarily a nonplace navigation strategy to locate the hidden platform," but in Experiment 2 we demonstrated that atropine sulfate-treated rats were able to form an accurate place response when special procedures designed to discourage nonplace strategies were used (see Figure 6 ). These data suggest that cholinergic systems are not necessary for rapid formation and storage of spatial relations between goal objects and distal cues.
The effects of atropine on motor behavior (Schallert et al., 1980) suggest that these animals can become trapped by their response to the physical characteristics of novel environments. They may adopt prepotent behavior patterns similar to that which undrugged rats initially adopt, but unlike the undrugged rats, they do not readily switch to more adaptive behaviors (DeVietti, Pellis, Peilis, & Teitelbaum, 1985; Schallert et al., 1980; see Hamm et al., 1992 , for similar results with traumatically brain-injured rats). Experiment 1 (see also Lindner & Schallert, 1988; Saucier, Hargreaves, Boon, Vanderwolf, & Cain, 1996) showed that, following the initial thigmotaxic response, atropine sulfate-treated rats are likely to shift gradually to stereotyped swim patterns (e.g., spirals or loops) in order to locate the platform hidden in the center of One of the quadrants. By preventing these typical behavior patterns from becoming reinforced in the first place (Experiment 2), Figure 6 . Comparison of mean latencies to find the hidden platform across the last four blocks of training and the probe trial for atropine sulfate-treated rats in Experiment 1 and Experiment 2.
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they were virtually eliminated. It remains unclear why preventing nonplace strategies allowed a place response to be used rather than some other behavior pattern. Anticholinergic drugs do not impair place learning if it is acquired previously in an undrugged state (Saucier et al., 1996; Whishaw, 1985) . Likewise, atropine-induced stereotyped behaviors, such as thigmotaxis, do not occur if animals are familiarized with the environment before receiving the drug (DeVietti et al., 1985; Saucier et al., 1996; Schallert et al., 1980) . Taken together with the present experiments, these studies suggest that cholinergic dysfunction may produce behavioral inflexibility by adversely affecting inhibitory control of strategy selection that masks, rather than impairs, place learning and perhaps other complex behavior--environment interactions. The rapid spatial learning in atropine sulfate-treated animals when the "shrinking platform" procedure was used to discourage nonplace behavioral patterns is consistent with the recent report by Baxter et al. (1995) . These investigators used a sensitive matching-to-place task, a modification of Whishaw's (1985) set-learning procedure, to examine the effects of the selective cholinergic toxin 192 IgG-saporin (infused either into the medial septum and vertical diagonal band to denervate the cholinergic input to the hippocampus or into the nucleus basalis and substantia innominata to denervate the cholinergic input to the neocortex). Deficits occurred after both lesions; however, because these deficits were memory independent, Baxter et al. suggested that, during the training trials, attentional processing was impaired rather than spatial learning and memory for the location of the platform per se. If so, then impairments in attentional mechanisms could possibly prevent strategy selection of appropriate associations that form the basis of efficient strategies. Conversely, it is possible that attentional deficits following cholinergic disruption could result from a failure to inhibit nonspatial behavioral patterns (as revealed in Experiment 2 of the present study) that, once locked in, interfere with attentional mechanisms required for acquisition of more adaptive behavior patterns (see also Amsel, 1993; Blodgett, McCutchan, & Mathews, 1949; Douglas, 1967; Gabriel, Sparenborg, & Stolar, 1987; Gray & McNaughton, 1983; Kimble, 1968) .
